Orrin Hatch: “Is it possible for FDA to trace adverse events and identify the source without a unique identifier in the name?”

Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.

I want to thank my dear colleague from Iowa. He is one of the greatest Senators I have served with. He is just a wonderful friend and a wonderful Senator. He has worked his tail off the whole time he has been here. I am grateful for his…

Having a confirmed Commissioner and sustained leadership will benefit the Social Security Administration.

I urge Congress pass the OPEN ACT before the end of this year.